Sailani Tours N Travels Ltd vs Sheel Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 22, 2026

Key Highlights

The Latest Trading Price of Sailani Tours N Travels Ltd is ₹ 18 as of 12 Mar 15:30 . The P/E Ratio of Sailani Tours N Travels Ltd is 40.5 as of March 2024 .The P/E Ratio of Sheel Biotech Ltd is 0 as of March 2024 . The Market Cap of Sailani Tours N Travels Ltd is ₹ 12 crore as of March 2024 .The Market Cap of Sheel Biotech Ltd is ₹ 0 crore as of March 2024 . The Dividend Payout of Sailani Tours N Travels Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sheel Biotech Ltd changed from 28.46 % on March 2022 to 14.05 % on March 2025 . This represents a CAGR of -16.18% over 4 years .

About Sailani Tours N Travels Ltd

Sailani Tours N Travels Limited was originally incorporated on September 26, 2019 as a Private Limited Company as 'Sailani Tours N Travels Private Limited' under the provisions of the Companies Act, 2013 with the Registrar of Companies.
Further, the Company converted into Public limited Company pursuant to Shareholders' Resolution passed at the Extra Ordinary General meeting held on September 10, 2021 and name was changed to 'Sailani Tours N Travels Limited' vide Fresh Certificate of Incorporation, dated October 07, 2021.
The Company is currently promoted by Mr. Krishna Kumar Chanani and Sunita Krishna Chanani to carry on the present business.
The Company is engaged in the business of Tour and Travel Agency services. The Company Promoter, Mr. Krishna Kumar Chanani was associated with a reputed travel agency, which led to an idea to have a space which provides all travel relating services under one roof which led to the origin of Sailani in the year 2019.

About Sheel Biotech Ltd

Sheel Biotech Limited was incorporated as a Private Company as 'Sheel Biotech Private Limited' dated November 26, 1991, with the Registrar of Companies, Delhi & Haryana.
Further, Company was converted into a Public Limited Company w.e.f.
April 02, 1992. The Company was founded by Dr. Satya Narayan Chandak in 1991.
Thereafter, through his vision he led the stone of Tissue Culture lab wherein for advancement of lab he deputed two of his scientists to Netherlands for training to expand the business ventured in domestic market too and then added greenhouse division to promote protected cultivation.
The Company started the Import division in 2019 and importing tulip, glad, lilium, orchids and alstromeria.

FAQs for the comparison of Sailani Tours N Travels Ltd and Sheel Biotech Ltd

Which company has a larger market capitalization, Sailani Tours N Travels Ltd or Sheel Biotech Ltd?

Market cap of Sailani Tours N Travels Ltd is 8 Cr while Market cap of Sheel Biotech Ltd is 99 Cr

What are the key factors driving the stock performance of Sailani Tours N Travels Ltd and Sheel Biotech Ltd?

The stock performance of Sailani Tours N Travels Ltd and Sheel Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sailani Tours N Travels Ltd and Sheel Biotech Ltd?

As of March 22, 2026, the Sailani Tours N Travels Ltd stock price is INR ₹18.0. On the other hand, Sheel Biotech Ltd stock price is INR ₹49.05.

How do dividend payouts of Sailani Tours N Travels Ltd and Sheel Biotech Ltd compare?

To compare the dividend payouts of Sailani Tours N Travels Ltd and Sheel Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.